The Power of Inhaled Nitric Oxide in a Cassette Patented technology enables administration of inhaled nitric oxide without tanks. Generates nitric oxide on demand while minimizing the potential exposure to NO 2.

2023年2月2日 · GENOSYL DS is the first tankless inhaled nitric oxide delivery system approved by the U.S. Food and Drug Administration (FDA). Inhaled Nitric Oxide dilates pulmonary blood vessels and may be used to improve oxygenation in neonates with hypoxic respiratory failure and pulmonary hypertension.

GENOSYL ® (nitric oxide) gas for inhalation, relaxes vascular smooth muscle cells, which leads to vasodilation of the pulmonary capillaries. GENOSYL appears to increase the partial pressure of arterial oxygen (PaO2) by dilating pulmonary vessels in better ventilated areas of the lung, redistributing pulmonary blood flow away from lung regions ...

2023年1月9日 · GENOSYL DS is the first tankless inhaled nitric oxide delivery system approved by the U.S. Food and Drug Administration (FDA). Inhaled Nitric Oxide dilates pulmonary blood vessels and may be used to improve oxygenation in neonates with hypoxic respiratory failure and pulmonary hypertension.

At VERO Biotech, our mission is to improve the lives of patients by developing innovative technologies for inhaled nitric oxide delivery in the acute care hospital setting and beyond; wherever nitric oxide treatment is needed.

2020年5月6日 · Inhaled Nitric Oxide. Inhaled Nitric Oxide as a therapeutic agent is ideally suited to its purpose—to effect dilation of pulmonary vessels, thereby lowering pulmonary artery pressures.

VERO Biotech’s technology enables nitric oxide generation on demand from the GENOSYL Cassette, an innovative alternative to the customary nitric oxide pressurized gas tanks.

Inhaled nitric oxide has revolutionized the treatment of PPHN by dilating the pulmonary vasculature, providing improved oxygenation and a reduced need for invasive extracorporeal membrane oxygenation (ECMO).

Vero Biotech’s GENOSYL Delivery System (DS) delivers GENOSYL (nitric oxide, NO) gas, for inhalation. The GENOSYL DS uses an injection and monitoring channel design to ensure safe delivery of NO.

GENOSYL ® (nitric oxide) gas for inhalation, relaxes vascular smooth muscle cells, which leads to vasodilation of the pulmonary capillaries. GENOSYL appears to increase the partial pressure of arterial oxygen (PaO2) by dilating pulmonary vessels in better ventilated areas of the lung, redistributing pulmonary blood flow away from lung regions ...